/
BDRX
$1.56+$0.06 (+4.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$1.5M
1M shares
52-week range
$1.02 – $59.40
1% from low
Exchange
NASDAQ
ADRC
Change$-47028.44
Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
www.biodexapharma.com- Employees
- 11
- IPO / List date
- Dec 7, 2015
Held by traders on TradeandTell
No one on the platform currently holds BDRX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BDRX as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-04-06 | 1-for-5reverse |
| 2025-07-31 | 1-for-10reverse |
| 2024-10-04 | 1-for-25reverse |
| 2023-07-05 | 1-for-80reverse |
| 2023-03-27 | 1-for-4reverse |
Recent trades on TradeandTell
No one on the platform has traded BDRX yet.
